• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Brexpiprazole Intermediate CAS:70500-72-0
Brexpiprazole CAS:913611-97-9
3-BROMOPHENANTHRENE
2-FLUORO-4-(TRIFLUOROMETHYL)BENZOPHENONE
3-BROMO-4-FLUOROBIPHENYL
9-TRIFLUOROACETYLANTHRACENE

Lupin launches generic Silodosin Capsules 4mg and 8mg

expressbpdDecember 05, 2018

Tag: lupin , Generic , Silodosin Capsules

Pharma major Lupin announced the launch of Silodosin Capsules 4mg and 8mg, having received an approval from the United States Food and Drug Administration (US FDA) earlier.

Lupin’s Silodosin Capsules 4mg and 8mg; is the generic equivalent of Allergan’s Rapaflo. An alpha-1 adrenergic receptor antagonist, it is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).

Rapaflo had annual sales of $ 198.5 million in the US (IQVIA MAT September 2018).

Previous:Trump's drug-prices-in-ads idea gets two more nay votes as federal comment deadline looms

Next:Teva hit with $6.3M retaliation verdict in age, anti-American discrimination suit

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Lupin launches generic Silodosin Capsules 4mg and 8mg | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Lupeol-98%-Lupinus Albus Extracts

Lupeol-98%-Lupinus Albus Extracts
Generic Diskus

Generic Diskus
Generic Soft Mist Inhaler

Generic Soft Mist Inhaler
20mm crimp on nasal pump, Dosed, Generic to, AB rated

20mm crimp on nasal pump, Dosed, Generic to, AB rated
Lupeol-8%-Lupinus Albus Extracts

Lupeol-8%-Lupinus Albus Extracts
Nasal pump for Generics

Nasal pump for Generics
Generic Breezhaler

Generic Breezhaler
PHENOXYMETHYL PENICILLIN POTASSIUM

PHENOXYMETHYL PENICILLIN POTASSIUM
LINCOMYCIN HCL

LINCOMYCIN HCL
GENTAMYCIN SULPHATE macrolides

GENTAMYCIN SULPHATE macrolides

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service